| Product Code: ETC9964493 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States continued to see a diverse range of dog and cat drug compounding import shipments from top exporting countries including Switzerland, Ireland, India, Italy, and Singapore. Despite a negative Compound Annual Growth Rate (CAGR) of -4.2% from 2020 to 2024, the market showed a significant decline with a growth rate of -38.36% from 2023 to 2024. The low Herfindahl-Hirschman Index (HHI) indicates a relatively low market concentration, reflecting the competitive landscape in the industry. The market remains dynamic with opportunities for further diversification and innovation.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Dog and Cat Drug Compounding Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Dog and Cat Drug Compounding Market - Industry Life Cycle |
3.4 United States (US) Dog and Cat Drug Compounding Market - Porter's Five Forces |
3.5 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume Share, By Dosages Form, 2022 & 2032F |
3.7 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume Share, By Animal Type, 2022 & 2032F |
4 United States (US) Dog and Cat Drug Compounding Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership trends in the United States |
4.2.2 Growing awareness about personalized healthcare for pets |
4.2.3 Rising demand for customized medication for dogs and cats |
4.2.4 Advancements in veterinary medicine and technology |
4.2.5 Increasing focus on pet health and wellness |
4.3 Market Restraints |
4.3.1 Regulatory challenges and compliance issues related to drug compounding for pets |
4.3.2 Lack of standardized guidelines for pet drug compounding |
4.3.3 Limited awareness among pet owners about the benefits of compounding medications for pets |
4.3.4 Competition from established pharmaceutical companies offering ready-made pet medications |
4.3.5 Concerns about the safety and efficacy of compounded drugs for pets |
5 United States (US) Dog and Cat Drug Compounding Market Trends |
6 United States (US) Dog and Cat Drug Compounding Market, By Types |
6.1 United States (US) Dog and Cat Drug Compounding Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Anti-infective Drugs, 2022 - 2032F |
6.1.4 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Anti-inflammatory Drugs, 2022 - 2032F |
6.1.5 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By CNS Agents, 2022 - 2032F |
6.1.6 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By GI Drugs, 2022 - 2032F |
6.1.7 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 United States (US) Dog and Cat Drug Compounding Market, By Dosages Form |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Tablets & Capsules, 2022 - 2032F |
6.2.3 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Powder, 2022 - 2032F |
6.2.4 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Solution, 2022 - 2032F |
6.2.5 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 United States (US) Dog and Cat Drug Compounding Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Oral, 2022 - 2032F |
6.3.3 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Injectable, 2022 - 2032F |
6.3.4 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Topical, 2022 - 2032F |
6.3.5 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 United States (US) Dog and Cat Drug Compounding Market, By Animal Type |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Dog, 2022 - 2032F |
6.4.3 United States (US) Dog and Cat Drug Compounding Market Revenues & Volume, By Cat, 2022 - 2032F |
7 United States (US) Dog and Cat Drug Compounding Market Import-Export Trade Statistics |
7.1 United States (US) Dog and Cat Drug Compounding Market Export to Major Countries |
7.2 United States (US) Dog and Cat Drug Compounding Market Imports from Major Countries |
8 United States (US) Dog and Cat Drug Compounding Market Key Performance Indicators |
8.1 Prescription refill rates for compounded pet medications |
8.2 Number of veterinary clinics offering drug compounding services |
8.3 Customer satisfaction and retention rates for pet owners using compounded medications |
8.4 Percentage increase in revenue from pet drug compounding services |
8.5 Number of new product developments or formulations in the dog and cat drug compounding market |
9 United States (US) Dog and Cat Drug Compounding Market - Opportunity Assessment |
9.1 United States (US) Dog and Cat Drug Compounding Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 United States (US) Dog and Cat Drug Compounding Market Opportunity Assessment, By Dosages Form, 2022 & 2032F |
9.3 United States (US) Dog and Cat Drug Compounding Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 United States (US) Dog and Cat Drug Compounding Market Opportunity Assessment, By Animal Type, 2022 & 2032F |
10 United States (US) Dog and Cat Drug Compounding Market - Competitive Landscape |
10.1 United States (US) Dog and Cat Drug Compounding Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Dog and Cat Drug Compounding Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here